Literature DB >> 21894242

Synthesis and characterization of novel fluorescent nitrogen-containing bisphosphonate imaging probes for bone active drugs.

Shuting Sun1, Katarzyna M Błażewska, Boris A Kashemirov, Anke J Roelofs, Fraser P Coxon, Michael J Rogers, Frank H Ebetino, Michael J McKenna, Charles E McKenna.   

Abstract

Progress in the synthesis of novel fluorescent conjugates of N-heterocyclic bisphosphonate drugs and related analogues, together with some recent applications of these compounds as imaging probes, are briefly discussed.

Entities:  

Year:  2011        PMID: 21894242      PMCID: PMC3166220          DOI: 10.1080/10426507.2010.526674

Source DB:  PubMed          Journal:  Phosphorus Sulfur Silicon Relat Elem        ISSN: 1026-7719


  4 in total

1.  Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.

Authors:  Boris A Kashemirov; Joy Lynn F Bala; Xiaolan Chen; F H Ebetino; Zhidao Xia; R Graham G Russell; Fraser P Coxon; Anke J Roelofs; Michael J Rogers; Charles E McKenna
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

Review 2.  Molecular mechanisms of action of bisphosphonates: current status.

Authors:  Anke J Roelofs; Keith Thompson; Sharon Gordon; Michael J Rogers
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

Review 3.  Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

Authors:  R G G Russell; N B Watts; F H Ebetino; M J Rogers
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

4.  Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo.

Authors:  Anke J Roelofs; Fraser P Coxon; Frank H Ebetino; Mark W Lundy; Zachary J Henneman; George H Nancollas; Shuting Sun; Katarzyna M Blazewska; Joy Lynn F Bala; Boris A Kashemirov; Aysha B Khalid; Charles E McKenna; Michael J Rogers
Journal:  J Bone Miner Res       Date:  2010-03       Impact factor: 6.741

  4 in total
  10 in total

1.  Bisphosphonate uptake in areas of tooth extraction or periapical disease.

Authors:  Simon Cheong; Shuting Sun; Benjamin Kang; Olga Bezouglaia; David Elashoff; Charles E McKenna; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Oral Maxillofac Surg       Date:  2014-07-12       Impact factor: 1.895

2.  Non-Ototoxic Local Delivery of Bisphosphonate to the Mammalian Cochlea.

Authors:  Woo Seok Kang; Shuting Sun; Kim Nguyen; Boris Kashemirov; Charles E McKenna; S Adam Hacking; Alicia M Quesnel; William F Sewell; Michael J McKenna; David H Jung
Journal:  Otol Neurotol       Date:  2015-07       Impact factor: 2.311

Review 3.  Farnesyl pyrophosphate synthase modulators: a patent review (2006 - 2010).

Authors:  Shuting Sun; Charles E McKenna
Journal:  Expert Opin Ther Pat       Date:  2011-06-25       Impact factor: 6.674

4.  Measurement of Ototoxicity Following Intracochlear Bisphosphonate Delivery.

Authors:  Woo Seok Kang; Kim Nguyen; Charles E McKenna; William F Sewell; Michael J McKenna; David H Jung
Journal:  Otol Neurotol       Date:  2016-07       Impact factor: 2.311

5.  Intracochlear Drug Delivery Through the Oval Window in Fresh Cadaveric Human Temporal Bones.

Authors:  Woo Seok Kang; Kim Nguyen; Charles E McKenna; William F Sewell; Michael J McKenna; David H Jung
Journal:  Otol Neurotol       Date:  2016-03       Impact factor: 2.311

6.  Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats.

Authors:  Akishige Hokugo; Shuting Sun; Sil Park; Charles E McKenna; Ichiro Nishimura
Journal:  Bone       Date:  2012-12-04       Impact factor: 4.398

7.  Endocytotic uptake of zoledronic acid by tubular cells may explain its renal effects in cancer patients receiving high doses of the compound.

Authors:  Anja Verhulst; Shuting Sun; Charles E McKenna; Patrick C D'Haese
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

8.  Development of oral osteomucosal tissue constructs in vitro and localization of fluorescently-labeled bisphosphonates to hard and soft tissue.

Authors:  Susan Bae; Shuting Sun; Tara Aghaloo; Ju-Eun Oh; Charles E McKenna; Mo K Kang; Ki-Hyuk Shin; Sotirios Tetradis; No-Hee Park; Reuben H Kim
Journal:  Int J Mol Med       Date:  2014-06-11       Impact factor: 4.101

9.  Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair: A review.

Authors:  I Qayoom; D B Raina; A Širka; Š Tarasevičius; M Tägil; A Kumar; L Lidgren
Journal:  Bone Joint Res       Date:  2018-11-03       Impact factor: 5.853

10.  Iodine-promoted stereoselective amidosulfenylation of electron-deficient alkynes.

Authors:  Fuhong Xiao; Dahan Wang; Shanshan Yuan; Huawen Huang; Guo-Jun Deng
Journal:  RSC Adv       Date:  2018-06-27       Impact factor: 4.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.